Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,601Revenue $M96.5Net Margin (%)-168.5Z-Score4.5
Enterprise Value $M3,593EPS $-0.3Operating Margin %-137.7F-Score2
P/E(ttm))0Cash Flow Per Share $-0.0Pre-tax Margin (%)-161.1Higher ROA y-yN
Price/Book3.910-y EBITDA Growth Rate %4.4Quick Ratio2.1Cash flow > EarningsY
Price/Sales38.45-y EBITDA Growth Rate %27.0Current Ratio2.3Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-12.0Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-19.3Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M429ROI % (ttm)-1.2Gross Margin Increase y-yN

Gurus Latest Trades with OPK

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
OPKGeorge Soros 2014-06-30 Reduce-0.12%$8.01 - $9.71
($8.73)
$ 8.39-4%Reduce -84.24%235,600
OPKGeorge Soros 2014-03-31 Add0.06%$7.58 - $9.96
($8.75)
$ 8.39-4%Add 76.98%1,494,800
OPKGeorge Soros 2013-09-30 Buy 0.07%$7.18 - $9.24
($8.02)
$ 8.395%New holding, 745000 sh.745,000
OPKMario Gabelli 2011-03-31 Reduce$3.48 - $4.83
($4.01)
$ 8.39109%Reduce -90.58%15,000
OPKMario Gabelli 2010-09-30 Add$2.07 - $2.6
($2.31)
$ 8.39263%Add 962%159,300
OPKMario Gabelli 2010-06-30 Reduce$1.87 - $2.55
($2.11)
$ 8.39298%Reduce -90%15,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

OPK is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
OPK Mario Gabelli 2014-06-3015,00000
OPK George Soros 2014-06-30235,6000.050.02-84.24%
Premium Most recent portfolio changes are included for Premium Members only!


OPK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2014-10-29Buy35,000$8.380.12view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2014-10-24Buy40,000$8.4-0.12view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2014-10-22Buy64,800$8.222.07view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2014-10-17Buy30,000$8.251.7view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2014-10-16Buy20,000$8.330.72view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2014-10-13Buy54,000$8.22.32view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2014-10-10Buy82,300$8.182.57view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2014-10-09Buy25,000$8.41-0.24view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2014-10-08Buy20,000$8.390view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2014-10-07Buy55,000$8.291.21view

Press Releases about OPK :

    Quarterly/Annual Reports about OPK:

    News about OPK:

    Articles On GuruFocus.com
    Weekly CEO Buys Highlight: NRP, OPK, GAM, KEY, ARWR Oct 20 2014 
    Weekly CEO Buys Highlight: NRP, SFXE, OPK, EPE, OMN Oct 12 2014 
    Highlight of This Week's Insider Buys Sep 30 2014 
    Weekly CEO Buys Highlight: CREG, OPK, LDOS, HALL, ULTA Sep 21 2014 
    Weekly CEO Buys Highlight: TITN, OPK, LDOS, FSFR, BRX Sep 16 2014 
    Weekly CEO Buys Highlight: OPK, BOBE, CONN, WPX, PHII Sep 08 2014 
    Weekly CEO Buys Highlight: TDG, OPK, QNST, PVA, CIO Sep 02 2014 
    Weekly CEO Buys Highlight: FSFR, FSIC, OPK, EPE, ACXM Aug 23 2014 
    Weekly CEO Buys Highlight: FSIC, NLY, OPK, GPC, ACXM Aug 17 2014 
    Weekly CEO Buys Highlight: APD, OCUL, CNMD, OPK, AEGR Aug 04 2014 

    More From Other Websites
    Cocrystal Pharma Develops Novel Ebola Screening Technology Oct 23 2014
    Neovasc, an OPKO Investee, Receives FDA Conditional Approval to Initiate TIARA-I Trial in U.S.: A... Oct 09 2014
    Mazor Robotics Ltd. (MZOR) in Focus: Stock Soars 11.3% Oct 07 2014
    OPKO Health Supports National Prostate Cancer Council Legislation Sep 29 2014
    OPKO Health (OPK) Reports Positive Data on Rayaldee Trial Sep 24 2014
    OPKO's Second Rayaldee Phase 3 Trial Meets Primary Endpoints Sep 23 2014
    OPKO Launches the 4Kscore Test in Europe Sep 15 2014
    Opko (OPK) Sees Hammer Chart Pattern: Time to Buy? Sep 12 2014
    Data Supporting Once-Weekly Dosing of hGH-CTP in Growth Hormone Deficient Pediatric Population to be... Sep 11 2014
    TESARO Seeks FDA Approval for NK-1 Receptor Rolapitant Sep 09 2014
    OPKO Licensee TESARO Submits New Drug Application for Rolapitant Sep 08 2014
    OPKO HEALTH, INC. Financials Aug 19 2014
    'Mad Money' Lightning Round: Don't Buy IBM Right Now Aug 14 2014
    Opko’s Frost Discusses Treatment of Kidney Disease (Audio) Aug 13 2014
    Taking Stock: Manley on Markets, Frost on Biotech (Audio) Aug 12 2014
    Taking Stock: Manley on Markets, Frost on Biotech Aug 12 2014
    OPKO HEALTH, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Aug 12 2014
    OPKO HEALTH, INC. Files SEC form 10-Q, Quarterly Report Aug 11 2014
    OPKO Announces Second Quarter Operating and Financial Results Aug 11 2014
    Rayaldee Phase 3 Trial Meets Primary Endpoints Aug 11 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK